The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Cell-Free Fetal DNA Testing-Global Market Insights and Sales Trends 2025
Synopsis
Cell-free DNA screening is a test that can determine if a woman has a higher chance of having a fetus with Down syndrome (trisomy 21), trisomy 18, trisomy 13 or an abnormality in the sex chromosomes (X and Y chromosomes). With this test, a sample of the woman's blood is taken after 10 weeks of pregnancy.
The global Cell-Free Fetal DNA Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cell-Free Fetal DNA Testing in various end use industries. The expanding demands from the Hospital and Clinic Center, are propelling Cell-Free Fetal DNA Testing market. Abnormal Chromosome Number Detection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Gender Testing segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Cell-Free Fetal DNA Testing market, driven by demand from China, the second largest economy with some signs of stabilising, the Cell-Free Fetal DNA Testing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cell-Free Fetal DNA Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cell-Free Fetal DNA Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cell-Free Fetal DNA Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cell-Free Fetal DNA Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cell-Free Fetal DNA Testing covered in this report include Roche, Arup Laboratories, PerkinElmer, Eurofins Biomnis, BGI, Berry Genomics, DAAN GENE, CapitalBio and Annoroad, etc.
The global Cell-Free Fetal DNA Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Arup Laboratories
PerkinElmer
Eurofins Biomnis
BGI
Berry Genomics
DAAN GENE
CapitalBio
Annoroad
ADICON
KingMed
Global Cell-Free Fetal DNA Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cell-Free Fetal DNA Testing market, Segment by Type:
Abnormal Chromosome Number Detection
Gender Testing
Paternally Inherited Disorder Detection
Paternity Testing
Others
Global Cell-Free Fetal DNA Testing market, by Application
Hospital
Clinic Center
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cell-Free Fetal DNA Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Cell-free DNA screening is a test that can determine if a woman has a higher chance of having a fetus with Down syndrome (trisomy 21), trisomy 18, trisomy 13 or an abnormality in the sex chromosomes (X and Y chromosomes). With this test, a sample of the woman's blood is taken after 10 weeks of pregnancy.
The global Cell-Free Fetal DNA Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cell-Free Fetal DNA Testing in various end use industries. The expanding demands from the Hospital and Clinic Center, are propelling Cell-Free Fetal DNA Testing market. Abnormal Chromosome Number Detection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Gender Testing segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Cell-Free Fetal DNA Testing market, driven by demand from China, the second largest economy with some signs of stabilising, the Cell-Free Fetal DNA Testing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cell-Free Fetal DNA Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cell-Free Fetal DNA Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cell-Free Fetal DNA Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cell-Free Fetal DNA Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cell-Free Fetal DNA Testing covered in this report include Roche, Arup Laboratories, PerkinElmer, Eurofins Biomnis, BGI, Berry Genomics, DAAN GENE, CapitalBio and Annoroad, etc.
The global Cell-Free Fetal DNA Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Arup Laboratories
PerkinElmer
Eurofins Biomnis
BGI
Berry Genomics
DAAN GENE
CapitalBio
Annoroad
ADICON
KingMed
Global Cell-Free Fetal DNA Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cell-Free Fetal DNA Testing market, Segment by Type:
Abnormal Chromosome Number Detection
Gender Testing
Paternally Inherited Disorder Detection
Paternity Testing
Others
Global Cell-Free Fetal DNA Testing market, by Application
Hospital
Clinic Center
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cell-Free Fetal DNA Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Cell-Free Fetal DNA Testing
1.1 Cell-Free Fetal DNA Testing Market Overview
1.1.1 Cell-Free Fetal DNA Testing Product Scope
1.1.2 Cell-Free Fetal DNA Testing Market Status and Outlook
1.2 Global Cell-Free Fetal DNA Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Cell-Free Fetal DNA Testing Market Size by Region (2018-2029)
1.4 Global Cell-Free Fetal DNA Testing Historic Market Size by Region (2018-2023)
1.5 Global Cell-Free Fetal DNA Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Cell-Free Fetal DNA Testing Market Size (2018-2029)
1.6.1 North America Cell-Free Fetal DNA Testing Market Size (2018-2029)
1.6.2 Europe Cell-Free Fetal DNA Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Cell-Free Fetal DNA Testing Market Size (2018-2029)
1.6.4 Latin America Cell-Free Fetal DNA Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Cell-Free Fetal DNA Testing Market Size (2018-2029)
2 Cell-Free Fetal DNA Testing Market by Type
2.1 Introduction
2.1.1 Abnormal Chromosome Number Detection
2.1.2 Gender Testing
2.1.3 Paternally Inherited Disorder Detection
2.1.4 Paternity Testing
2.1.5 Others
2.2 Global Cell-Free Fetal DNA Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Cell-Free Fetal DNA Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Cell-Free Fetal DNA Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Cell-Free Fetal DNA Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Cell-Free Fetal DNA Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Cell-Free Fetal DNA Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Cell-Free Fetal DNA Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Cell-Free Fetal DNA Testing Revenue Breakdown by Type (2018-2029)
3 Cell-Free Fetal DNA Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic Center
3.2 Global Cell-Free Fetal DNA Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Cell-Free Fetal DNA Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Cell-Free Fetal DNA Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Cell-Free Fetal DNA Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Cell-Free Fetal DNA Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Cell-Free Fetal DNA Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Cell-Free Fetal DNA Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Cell-Free Fetal DNA Testing Revenue Breakdown by Application (2018-2029)
4 Cell-Free Fetal DNA Testing Competition Analysis by Players
4.1 Global Cell-Free Fetal DNA Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cell-Free Fetal DNA Testing as of 2022)
4.3 Date of Key Players Enter into Cell-Free Fetal DNA Testing Market
4.4 Global Top Players Cell-Free Fetal DNA Testing Headquarters and Area Served
4.5 Key Players Cell-Free Fetal DNA Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Cell-Free Fetal DNA Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Roche
5.1.1 Roche Profile
5.1.2 Roche Main Business
5.1.3 Roche Cell-Free Fetal DNA Testing Products, Services and Solutions
5.1.4 Roche Cell-Free Fetal DNA Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Roche Recent Developments
5.2 Arup Laboratories
5.2.1 Arup Laboratories Profile
5.2.2 Arup Laboratories Main Business
5.2.3 Arup Laboratories Cell-Free Fetal DNA Testing Products, Services and Solutions
5.2.4 Arup Laboratories Cell-Free Fetal DNA Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Arup Laboratories Recent Developments
5.3 PerkinElmer
5.3.1 PerkinElmer Profile
5.3.2 PerkinElmer Main Business
5.3.3 PerkinElmer Cell-Free Fetal DNA Testing Products, Services and Solutions
5.3.4 PerkinElmer Cell-Free Fetal DNA Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Eurofins Biomnis Recent Developments
5.4 Eurofins Biomnis
5.4.1 Eurofins Biomnis Profile
5.4.2 Eurofins Biomnis Main Business
5.4.3 Eurofins Biomnis Cell-Free Fetal DNA Testing Products, Services and Solutions
5.4.4 Eurofins Biomnis Cell-Free Fetal DNA Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Eurofins Biomnis Recent Developments
5.5 BGI
5.5.1 BGI Profile
5.5.2 BGI Main Business
5.5.3 BGI Cell-Free Fetal DNA Testing Products, Services and Solutions
5.5.4 BGI Cell-Free Fetal DNA Testing Revenue (US$ Million) & (2018-2023)
5.5.5 BGI Recent Developments
5.6 Berry Genomics
5.6.1 Berry Genomics Profile
5.6.2 Berry Genomics Main Business
5.6.3 Berry Genomics Cell-Free Fetal DNA Testing Products, Services and Solutions
5.6.4 Berry Genomics Cell-Free Fetal DNA Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Berry Genomics Recent Developments
5.7 DAAN GENE
5.7.1 DAAN GENE Profile
5.7.2 DAAN GENE Main Business
5.7.3 DAAN GENE Cell-Free Fetal DNA Testing Products, Services and Solutions
5.7.4 DAAN GENE Cell-Free Fetal DNA Testing Revenue (US$ Million) & (2018-2023)
5.7.5 DAAN GENE Recent Developments
5.8 CapitalBio
5.8.1 CapitalBio Profile
5.8.2 CapitalBio Main Business
5.8.3 CapitalBio Cell-Free Fetal DNA Testing Products, Services and Solutions
5.8.4 CapitalBio Cell-Free Fetal DNA Testing Revenue (US$ Million) & (2018-2023)
5.8.5 CapitalBio Recent Developments
5.9 Annoroad
5.9.1 Annoroad Profile
5.9.2 Annoroad Main Business
5.9.3 Annoroad Cell-Free Fetal DNA Testing Products, Services and Solutions
5.9.4 Annoroad Cell-Free Fetal DNA Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Annoroad Recent Developments
5.10 ADICON
5.10.1 ADICON Profile
5.10.2 ADICON Main Business
5.10.3 ADICON Cell-Free Fetal DNA Testing Products, Services and Solutions
5.10.4 ADICON Cell-Free Fetal DNA Testing Revenue (US$ Million) & (2018-2023)
5.10.5 ADICON Recent Developments
5.11 KingMed
5.11.1 KingMed Profile
5.11.2 KingMed Main Business
5.11.3 KingMed Cell-Free Fetal DNA Testing Products, Services and Solutions
5.11.4 KingMed Cell-Free Fetal DNA Testing Revenue (US$ Million) & (2018-2023)
5.11.5 KingMed Recent Developments
6 North America
6.1 North America Cell-Free Fetal DNA Testing Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Cell-Free Fetal DNA Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cell-Free Fetal DNA Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cell-Free Fetal DNA Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cell-Free Fetal DNA Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cell-Free Fetal DNA Testing Market Dynamics
11.1 Cell-Free Fetal DNA Testing Industry Trends
11.2 Cell-Free Fetal DNA Testing Market Drivers
11.3 Cell-Free Fetal DNA Testing Market Challenges
11.4 Cell-Free Fetal DNA Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
